Voiding & Outlet Pharmacotherapy
Pharmacotherapy targeting bladder outlet relaxation, voiding-phase contraction, and outlet tone — the medical companion to surgical management of BPH/LUTS, stress incontinence, underactive bladder, and detrusor-sphincter dyssynergia. Most agents act at three loci: the bladder neck and prostatic smooth muscle (α₁ receptors), the detrusor (cholinergic receptors), and the external sphincter and pelvic floor (skeletal muscle).
For OAB / storage-phase therapy see Storage & OAB. For pelvic-floor hypertonicity in the context of neuropathic pelvic pain see Neuropathic & Pelvic Pain.
- α-BlockersTamsulosin, silodosin, alfuzosin, doxazosin, terazosin. BPH/LUTS first-line; medical expulsive therapy for distal ureteral stones > 5 mm; trial without catheter (TWOC) after AUR; CP/CPPS adjunct; intraoperative floppy iris syndrome (IFIS) and orthostatic hypotension as the dominant safety signals.
- 5α-Reductase InhibitorsFinasteride and dutasteride. BPH with prostate ≥ 30 mL; MTOPS combination with α-blocker; PSA halving rule for screening; the PCPT / REDUCE high-grade-cancer detection-bias controversy; cosmetic indications (hair loss).
- α-AgonistsMidodrine, pseudoephedrine, phenylephrine. Mild SUI (off-label, rarely effective); priapism self-detumescence; orthostatic hypotension in autonomic dysfunction; phenylephrine as the standard intracavernosal rescue for ischemic priapism.
- Cholinergic AgonistsBethanechol as the canonical agent. Underactive bladder / detrusor underactivity — limited efficacy data, largely legacy. CIC outperforms across modern series. Absolute contraindication in outlet obstruction.
- Skeletal Muscle RelaxantsCyclobenzaprine, baclofen, tizanidine, methocarbamol. Pelvic-floor hypertonicity; baclofen for detrusor-sphincter dyssynergia (oral and intrathecal); vaginal-diazepam adjunct framing.
- DantroleneDirect skeletal-muscle relaxant for refractory dyssynergia — historical role. Hepatotoxicity limits modern use; largely supplanted by botulinum toxin to the external sphincter.